Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (261-270 of 451) with videos related to

Pageof 46
Sort By:
The Lancet. Gastroenterology & Hepatology|October 4, 2020
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysisKeeley M Fairbrass, Sarah J Costantino, David J Gracie, et al.
The Cochrane Database of Systematic Reviews|April 20, 2016
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive peopleAlexander C Ford, Kurinchi Selvan Gurusamy, Brendan Delaney, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2009
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford, Brennan M R Spiegel, Nicholas J Talley, et al.
BMJ (Clinical Research Ed.)|December 13, 2019
Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysisLeonardo H Eusebi, Christopher J Black, Colin W Howden, et al.
Gut|December 23, 2021
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysisNicholas E Burr, David J Gracie, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2023
ReplyVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2022
Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-upKeeley M Fairbrass, P John Hamlin, David J Gracie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
Gastroenterology|April 15, 2020
Peppermint Oil in Irritable Bowel SyndromeChristopher J Black, Paul Moayyedi, Eamonn M M Quigley, et al.
Pageof 46

Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
The Lancet. Gastroenterology & Hepatology|October 4, 2020
Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysisKeeley M Fairbrass, Sarah J Costantino, David J Gracie, et al.
The Cochrane Database of Systematic Reviews|April 20, 2016
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive peopleAlexander C Ford, Kurinchi Selvan Gurusamy, Brendan Delaney, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2009
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford, Brennan M R Spiegel, Nicholas J Talley, et al.
BMJ (Clinical Research Ed.)|December 13, 2019
Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysisLeonardo H Eusebi, Christopher J Black, Colin W Howden, et al.
Gut|December 23, 2021
Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysisNicholas E Burr, David J Gracie, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2023
ReplyVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2022
Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-upKeeley M Fairbrass, P John Hamlin, David J Gracie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
Gastroenterology|April 15, 2020
Peppermint Oil in Irritable Bowel SyndromeChristopher J Black, Paul Moayyedi, Eamonn M M Quigley, et al.
Pageof 46